ADD CONDITION

items per page

Yowch for Minor Burns by Pain Balm

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Lidocaine Hydrochloride 20 mg/1000 mg
Other brand names
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2015
Label revision date
September 2, 2015
Active ingredient
Lidocaine Hydrochloride 20 mg/1000 mg
Other brand names
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2015
Label revision date
September 2, 2015
Manufacturer
Ridge Properties
Registration number
part348
NDC root
69804-004

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

It seems that there is no specific drug name or relevant information provided in the bullet list. Without details about a particular medication, its uses, or how it works, I am unable to create a summary for you. If you have specific information about a drug, please share it, and I would be happy to help!

Uses

It seems that there are no specific uses or indications provided for this medication. This means that the information about what this drug is intended to treat or how it can be used is currently unavailable. If you have any questions or need further information, it's best to consult with a healthcare professional who can provide guidance based on your individual health needs.

Dosage and Administration

It seems that specific dosage and administration information for the medication you are inquiring about is not available in the provided text. Instead, there is a reference to an image titled "directions.jpg" that likely contains the necessary details on how to take or apply the medication.

To ensure you use the medication correctly, I recommend checking that image for the exact instructions. If you have any questions or need further clarification, please consult your healthcare provider or pharmacist for guidance tailored to your situation. They can provide you with the most accurate and safe information regarding your medication.

What to Avoid

You can feel reassured that there are no specific contraindications, controlled substance classifications, or concerns regarding abuse, misuse, or dependence associated with this medication. This means that, based on the available information, there are no known restrictions or risks that would prevent you from using it safely. Always consult with your healthcare provider if you have any questions or concerns about your treatment.

Side Effects

You may not experience any specific side effects while using this medication, as there are no documented adverse reactions or warnings associated with it. It's always a good idea to monitor how you feel and consult your healthcare provider if you have any concerns or unusual symptoms.

Warnings and Precautions

It appears that there are no specific warnings, precautions, or instructions provided in the information available. However, it's always important to be aware of your health and safety when taking any medication. If you experience any unusual symptoms or side effects, it's crucial to stop taking the medication and consult your doctor immediately.

Additionally, if you ever feel that you are having a medical emergency, do not hesitate to seek emergency medical help right away. Always keep open communication with your healthcare provider about any concerns or questions you may have regarding your treatment.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While the specific signs of an overdose are not detailed, common symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are unsure, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's crucial to provide them with as much information as possible about the substance taken and the amount, if known. Remember, acting quickly can make a significant difference in your health and safety.

Pregnancy Use

When it comes to using YOWCH FOR MINOR BURNS BY PAIN BALM, which contains lidocaine hydrochloride cream, there is currently no information available about its safety or recommended use during pregnancy. This means that there are no specific guidelines regarding dosage adjustments or precautions for pregnant individuals.

If you are pregnant or planning to become pregnant, it’s important to consult with your healthcare provider before using this product. They can help you understand any potential risks and guide you on the best options for managing discomfort during this time.

Lactation Use

If you are breastfeeding or planning to breastfeed, you can feel reassured that there are no specific warnings or recommendations regarding nursing mothers or lactation in the information provided. This means that, based on the available data, there are no known risks associated with breastfeeding while using this medication. However, it's always a good idea to consult with your healthcare provider about any concerns you may have regarding your health and breastfeeding.

Pediatric Use

When considering this medication for your child, it's important to know that its safety and effectiveness have not been established in pediatric patients (children). Therefore, it is not recommended for use in children under 2 years of age. Always consult with your child's healthcare provider for guidance on appropriate treatments and medications.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider for personalized advice. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that you may need a lower dose of the medication. Before starting treatment, your healthcare provider will assess your creatinine clearance (a test that measures how well your kidneys are filtering waste). Regular tests to monitor your kidney function are also recommended to ensure your safety while on this medication.

For those with significant renal impairment, special monitoring may be necessary to prevent potential toxicity. Always communicate with your healthcare provider about your kidney health to ensure the best treatment plan for you.

Hepatic Impairment

If you have liver problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations apply, but you should always consult your healthcare provider for personalized advice. They can help determine the best approach for your treatment and monitor your liver function as needed.

Make sure to keep your doctor informed about your liver health, as they may want to conduct regular tests to ensure your safety while using any medication. Your well-being is a priority, and your healthcare team is there to support you.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications you are taking, even if there are no specific drug interactions or laboratory test interactions noted for your treatment. This ensures that your healthcare team can monitor your health effectively and make informed decisions about your care.

Always feel free to ask questions and share any other medications or supplements you might be using. This way, you can work together to ensure your treatment is safe and effective.

Storage and Handling

To ensure the best performance of your product, store it in a cool, dry place at a temperature between 20°C and 25°C (68°F to 77°F). It’s acceptable for the temperature to occasionally range from 15°C to 30°C (59°F to 86°F), but try to keep it within the recommended limits. Make sure to protect the product from light and always keep the container tightly closed when not in use.

Once you open the container, remember to discard any remaining product, as it is no longer safe to use. Following these guidelines will help maintain the product's effectiveness and safety.

Additional Information

No further information is available.

FAQ

What should I know about using this medication in children?

The product is not recommended for use in children under 2 years of age, and safety and effectiveness in pediatric patients have not been established.

What precautions should I take if I have renal impairment?

If you have renal impairment, your creatinine clearance should be assessed before starting therapy, and regular renal function tests are recommended to avoid potential toxicity.

What are the storage conditions for this medication?

Store the medication at 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). Protect it from light and keep the container tightly closed.

Is there any information regarding use during pregnancy?

There is no information provided regarding the safety or dosage modifications for use during pregnancy.

Are there any specific warnings for nursing mothers?

The text does not provide specific warnings or recommendations regarding nursing mothers.

What should I do if I experience side effects?

The text does not list specific side effects, but you should consult your doctor if you have any concerns.

Packaging Info

Below are the non-prescription pack sizes of Yowch for Minor Burns by Pain Balm (lidocaine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Yowch for Minor Burns by Pain Balm.
Details

Drug Information (PDF)

This file contains official product information for Yowch for Minor Burns by Pain Balm, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

The product is a burn cream, designed for topical application. It is packaged in a 2 oz container, ensuring convenient use and storage.

Uses and Indications

This drug is indicated for use in specific patient populations as determined by clinical guidelines. Currently, there are no detailed indications and usage information available. There are no known teratogenic or nonteratogenic effects associated with this drug. Healthcare professionals are advised to refer to the latest clinical guidelines and studies for further information regarding appropriate use and patient selection.

Dosage and Administration

Healthcare professionals are advised to refer to the accompanying image ("directions.jpg") for comprehensive dosage and administration information. This image contains essential details regarding the appropriate dosing ranges, administration routes, methods, and frequency of administration. It is crucial to follow the outlined instructions to ensure safe and effective use of the medication.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

The absence of specific warnings, general precautions, laboratory tests, and instructions for emergency medical help or cessation of use indicates that there are no documented concerns or recommendations associated with the use of this product. Healthcare professionals are advised to remain vigilant and apply clinical judgment when prescribing or administering this treatment, considering the individual patient's health status and any potential interactions with other medications.

In the absence of detailed laboratory monitoring parameters, it is prudent for healthcare providers to assess the patient's overall health and conduct routine evaluations as necessary. Should any unusual symptoms or adverse reactions arise, immediate consultation with a healthcare professional is recommended to ensure patient safety and appropriate management.

Healthcare professionals should maintain open communication with patients regarding any changes in their condition and encourage them to report any side effects or concerns promptly. This proactive approach will help in the effective monitoring of the patient's response to treatment and in making informed decisions regarding ongoing care.

Side Effects

There are no specific adverse reactions reported in the warnings section, the adverse reactions section, or in any additional notes. As such, no side effects have been identified for this product based on the available data.

Drug Interactions

No specific drug interactions have been identified in the available data. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Yowch for Minor Burns by Pain Balm (lidocaine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Yowch for Minor Burns by Pain Balm.
Details

Pediatric Use

Safety and effectiveness in pediatric patients have not been established. The product is not recommended for use in children under 2 years of age.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no information available regarding the use of YOWCH FOR MINOR BURNS BY PAIN BALM - lidocaine hcl cream during pregnancy. Consequently, the safety of this medication in pregnant patients has not been established, and there are no known dosage modifications or special precautions recommended for use in this population. Healthcare professionals should exercise caution when considering the use of this product in women of childbearing potential and weigh the potential risks against the benefits.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific concerns have been identified.

Renal Impairment

Patients with renal impairment may necessitate a reduced dose of the medication. It is essential for healthcare professionals to assess creatinine clearance prior to initiating therapy in this patient population. Regular renal function tests are recommended for patients with existing kidney problems to monitor their condition effectively. Additionally, special monitoring may be required for patients with significant renal impairment to avoid potential toxicity associated with the medication.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, and respiratory distress.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

If the substance involved is known, specific antidotes or treatments may be indicated. Consultation with a poison control center or a medical toxicologist is recommended for guidance on the appropriate management strategies tailored to the specific situation.

Documentation of the incident, including the substance, amount ingested, and time of exposure, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the necessity of proper storage to ensure the safety of young individuals.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain integrity. It should be stored at a temperature range of 20°C to 25°C (68°F to 77°F), with permissible excursions between 15°C to 30°C (59°F to 86°F). It is essential to protect the product from light to prevent degradation. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Yowch for Minor Burns by Pain Balm, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Yowch for Minor Burns by Pain Balm, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.